Spontaneous hemorrhage of cavernous malformation in the region of the cochlear nucleus: A case report Authors: Rouda Almaazmi, Azan Ahmad, Kurt Schlemmer, Mohammed Asif Dogar Published: 2026 ABSTRACT AbstractCerebral cavernous malformations (CMs) are low-flow, thin-walled vascular lesions affecting approximately 0.5%-0.9% of the population; they rarely arise at the skull base, and involvement of the cerebellopontine angle (CPA) is exceptionally uncommon, with only 19-21 cases reported and no prior description of cochlear nucleus involvement. We report a previously healthy 33-year-old woman who presented acutely with right-sided temporal headache, severe vertigo, sensorineural hearing loss, otalgia, and facial weakness. Multisequential MRI, including susceptibility-weighted imaging (SWI), demonstrated a hemorrhagic CM centered on the right cochlear nucleus with CPA extension and a co-existing developmental venous anomaly, allowing confident noninvasive diagnosis. She was managed conservatively with corticosteroids and multidisciplinary follow-up; at 1-year, facial weakness and vertigo had fully resolved, but severe-to-profound sensorineural hearing loss persisted. To the best of our knowledge, this represents one of the very few, if not the first, reported cases of hemorrhagic CM confined to the cochlear nucleus with CPA extension, underscoring the value of multisequential MRI in avoiding unnecessary invasive procedures.Keywords: Cerebral cavernous malformation, Cochlear nucleus, Cerebellopontine angle, Sensorineural hearing loss, Developmental venous anomaly, magnetic resonance imaging Introduction Cavernous malformations (CMs), also known as cavernomas or cavernous hemangiomas, are clusters of abnormal sinusoidal venous capillaries lined by a single layer of endothelium and characterized by recurrent microhemorrhages, hemosiderin deposition, and surrounding gliosis. Histologically, they lack smooth muscle, intervening neural parenchyma, and arterial elements [1]. CMs affect approximately 0.5%-0.9% of the general population; approximately 80% are sporadic and 20% are familial, with sporadic lesions frequently associated with a subjacent developmental venous anomaly (DVA) [2]. Although CMs may occur anywhere in the central nervous system, the vast majority arise in the cerebral hemispheres, followed by the basal ganglia, brainstem, cerebellum, and spinal cord. The cerebellopontine angle (CPA) represents an exceedingly rare site, accounting for fewer than 0.4% of all CMs, with only 19-21 cases described to date [2,3]. Most CMs remain clinically silent. When symptomatic, presentation depends on location and includes seizures (40%-80%), focal neurological deficits (25%-50%), and intracranial hemorrhage (25%-40%) [2]. Skull-base CMs involving the CPA may injure cranial nerves VII and VIII, mimicking vestibular schwannoma and creating significant diagnostic challenges. We report a case of acute hemorrhagic CM originating in the region of the right cochlear nucleus, with extension into the CPA, and discuss the role of multisequential MRI including SWI in establishing the diagnosis without recourse to invasive procedures. At presentation, the patient had deficits in both the cochlear and vestibular components of the eighth cranial nerve, together with clinical facial nerve weakness. Close follow-up over the subsequent year demonstrated complete recovery of the vestibular and facial nerve deficits, whereas no recovery occurred in the cochlear component a pattern consistent with an epicenter of injury within the cochlear nucleus itself, exerting secondary pressure effects on the adjacent facial and vestibular nerve fibers. Case presentation A previously healthy 33-year-old woman presented to the emergency department with sudden-onset right-sided temporal headache, severe vertigo with vomiting, right-sided otalgia, and hearing loss of 2 days’ duration. She reported that symptoms had begun abruptly and progressed over 48 hours, prompting presentation to an outside facility. Over this period, she developed right-sided facial weakness, which precipitated her attendance at our center. She denied any previous trauma, recent viral illness, radiation exposure, or family history of neurological disorders. On examination, the patient was alert and oriented. Right-sided facial weakness was graded House–Brackmann (HB) VI. Spontaneous nystagmus independent of visual fixation was present; the head impulse test demonstrated overt corrective saccades during rightward head impulse, consistent with right-sided peripheral vestibular hypofunction. Otoscopic findings were unremarkable. Weber testing lateralized to the left; Rinne’s test was positive bilaterally. The Hitzelberger sign was negative; gait and coordination were normal. CT and MRI demonstrated a right-sided fusiform hemorrhagic lesion medial to the foramen of Luschka at the typical anatomical location of the cochlear nucleus, extending along the eighth cranial nerve into the right CPA (Fig. 1). CT and catheter angiography showed no arteriovenous malformation or aneurysm. Contrast-enhanced MRI revealed no enhancing mass but identified a subjacent enhancing DVA in close anatomical relation to the hemorrhage Fig. 2). Axial, coronal, and sagittal noncontrast CT images demonstrate a fusiform, hyperdense brainstem hemorrhage (Hounsfield units [HU] ≈ 67) immediately medial to the foramen of Luschka, corresponding to the typical location of the cochlear nucleus. Axial multisequential MRI (T1 precontrast, T1 postcontrast, T2, and SWI, left to right) of the right cochlear nucleus/CPA lesion at 3 time points; no contrast enhancement is identified on any sequence or time point. Row 1 (Day 1): consistent with acute hemorrhage (deoxyhemoglobin). Row 2 (Day 19): in keeping with subacute hemorrhage (methemoglobin). Row 3 (Day 217): consistent with chronic hemorrhage. Row 4: Axial T1 postcontrast MRI demonstrates an enhancing developmental venous anomaly subjacent to the cochlear nucleus hemorrhage (white arrow); noncontrast T1 shown for reference. Initial management comprised high-dose prednisolone (80 mg/d for 7 days, tapered by 20 mg every 5 days) and prochlorperazine as a labyrinthine sedative. Corticosteroids were administered empirically to reduce perilesional edema given the acute clinical presentation and to address the acute CN VII and VIII deficits, whilst imaging evolution and multidisciplinary review were awaited. Formal audiological evaluation is summarized in Table 1 and illustrated in Fig. 3. Initial assessment demonstrated right-sided profound SNHL with complete speech discrimination loss (SRT: no response at maximum 110 dB HL; WRS: 0%). Left-ear thresholds were normal (SRT 10 dB HL, WRS 100% at 40 dB HL). At 4-month follow-up, marginal threshold improvement was noted, but severe-to-profound SNHL persisted (right SRT unobtainable at 90 dB HL due to stimulus intolerance). By 12 months, right-sided SNHL was judged permanent; Contralateral Routing of Signal (CROS) hearing aid rehabilitation was initiated. Table 1Summary of audiological findings at initial presentation and 4-month follow-up.Table 1 dummy alt textParameterInitial: RightInitial: Left4 mo: Right4 mo: Left1-y outcomePure-tone thresholdsProfound SNHLNormalSevere–profoundNormalPersistent severe–profound SNHL (right)SRTNo response at max 110 dB HL10 dB HLNo response at 90 dB HLNormalNo improvementWRS/SDS0% (no response at 110 dB HL)100% at 40 dB HLCannot tolerate 90 dB HL100% at 55 dB HLNo discrimination (right)TympanometryType AType AType AType ANormal bilaterallyVestibular symptomsSevere vertigo, nystagmus, positive HIT (right)N/AImprovingN/AComplete resolutionFacial nerve (CN VII)HB Grade VINormalRecoveringNormalComplete recoveryHB, House–Brackmann; HIT, head impulse test; N/A, not applicable; SNHL, sensorineural hearing loss; SRT, Speech Recognition Threshold; WRS/SDS, Word Recognition Score/Speech Discrimination Score. Summary of audiological findings at initial presentation and 4-month follow-up. HB, House–Brackmann; HIT, head impulse test; N/A, not applicable; SNHL, sensorineural hearing loss; SRT, Speech Recognition Threshold; WRS/SDS, Word Recognition Score/Speech Discrimination Score. Serial pure-tone audiograms and tympanograms at initial presentation and 4-month follow-up. At 12-month review, facial weakness and vertigo had fully resolved. Repeat MRI at 6 months demonstrated hemorrhage evolution from acute to chronic signal without lesion growth, supporting the CM diagnosis. Conservative management with surveillance MRI was continued. Discussion CMs are slow-flow vascular malformations with a recognized propensity for recurrent microhemorrhages. The present case is noteworthy for the precise anatomical confinement of the CM hemorrhage to the cochlear nucleus a location not previously described in the literature with secondary extension along the eighth cranial nerve into the CPA. Anatomical considerations The cochlear nucleus lies on the dorsolateral surface of the inferior cerebellar peduncle at the pontomedullary junction, just medial to the foramen of Luschka, closely opposed to the root entry zone of the eighth cranial nerve. A CM arising within this nucleus can therefore produce combined central (nuclear) and peripheral (root/CPA) hemorrhagic injury, explaining both the clinical deficits and the imaging appearance of a fusiform lesion extending from the foramen of Luschka into the CPA (Fig. 1). Differential diagnosis The principal differential diagnoses for a hemorrhagic CPA–brainstem lesion include: (1) Hemorrhagic vestibular schwannoma; the most common CPA tumor; unlike CM, schwannomas typically show avid gadolinium enhancement, arise from the internal auditory canal, and lack a peripheral hemosiderin rim on SWI. (2) Hemorrhagic brainstem glioma; infiltrative, often enhancing, without the well-demarcated hemosiderin-rimmed appearance of CM. (3) Hemorrhagic metastasis; almost invariably associated with ring or nodular enhancement, vasogenic edema, and absent SWI “blooming.” (4) Meningioma; enhances uniformly with a Dural tail; hemorrhage is uncommon. The absence of gadolinium enhancement throughout the imaging course and negative angiography effectively excluded these vascular and mass lesions in the present case. Role of MRI and SWI SWI is exquisitely sensitive to the paramagnetic susceptibility effects of deoxyhemoglobin in acute hemorrhage, enabling detection when T1/T2 sequences may be equivocal. As hemorrhage evolves deoxyhemoglobin (acute) then methemoglobin (subacute) and hemosiderin (chronic) the signal changes are trackable across MRI sequences and are illustrated across time points in Fig. 2 [4]. SWI “blooming” and the T2 hemosiderin rim are hallmarks that reliably distinguish CM from enhancing CPA mass lesions. The presence of a subjacent DVA further supports the diagnosis of sporadic CM. Meng et al. reported concurrent DVA in up to 33% of sporadic CM cases, and emerging evidence suggests DVAs may predispose to adjacent CM formation through chronic venous hypertension [5]. A similarly located posterior fossa lesion with an associated DVA has recently been reported to mimic a CPA neoplasm on CT, reinforcing the value of multisequential MRI including SWI in distinguishing CM from enhancing mass lesions at this site [6]. Steroid therapy—Rationale and limitations High-dose prednisolone was administered empirically given a presumptive working diagnosis of hemorrhagic CM or atypical schwannoma with hemorrhagic transformation, targeting perilesional edema and attenuation of the inflammatory response. Corticosteroids are not a standard therapy for established CMs, and prospective evidence supporting their use in this context is lacking this is acknowledged as a limitation. Once CM was confirmed on follow-up imaging, steroids were tapered and discontinued; no lesion growth or rebleeding was observed. The complete resolution of facial weakness and vestibular symptoms at 12 months contrasts with the persistence of severe-to-profound SNHL, reflecting the greater regenerative capacity of CN VII and the vestibular nucleus compared with the cochlear nucleus following focal hemorrhagic injury an important prognostic consideration for patient counselling. Conclusion To the best of our knowledge, this represents one of the very few if not the first reported cases of hemorrhagic CM confined to the cochlear nucleus with CPA extension. Multisequential MRI, including SWI and serial gadolinium-enhanced sequences, is essential for accurate characterization and can preclude invasive diagnostic procedures. Longitudinal imaging and close multidisciplinary collaboration between neurosurgery, neuroradiology, and otolaryngology are fundamental to the management of such rare lesions. Patient consent The written informed consent was obtained from the patient for publication of this case report and any accompanying images. Footnotes Competing Interests: The authors have declared that no competing interests exist. References